Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

GNL vs SBRA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBRA Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 8–2 Matrix Metrics)

SBRA Overall Winner 6-Pillar Tally: GNL 3 – 3 SBRA Matrix Metrics: GNL 2 – 8 SBRA

As of Nov 17, 2026, Sabra Healthcare REIT, Inc. (SBRA) is the stronger overall head-to-head candidate over Global Net Lease, Inc. (GNL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). GNL carries a Unified Composite Score of 29.1/100 (SELL) at $6.28 (N/M Forward P/E, 34.8% operating margin), whereas SBRA carries 58.3/100 (HOLD) at $20.25 (30.4x Forward P/E, 18.4% operating margin).

  • Technical & Structure Timing Caution: GNL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.0); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GNL vs SBRA
GNL NYSE
Global Net Lease, Inc.
Real Estate Investment Trusts
$6.28
-2.71% 1D
Market Cap $1.5B
TTM Revenue $452M
Forward P/E N/M
Beta / 30D Vol 0.21β · 29% Vol
Unified Composite Score
29.1 / 100 SELL
Tech 23.0 Fund 38.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -10.0%), weak momentum, RSI 20
RSI-14: 20.0 · SMA20: $6.92 · SMA50: $7.75
SBRA NASDAQ Head-to-Head Winner
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.25
-0.47% 1D
Market Cap $5.4B
TTM Revenue $924M
Forward P/E 30.4x
Beta / 30D Vol 0.00β · 30% Vol
Unified Composite Score
58.3 / 100 HOLD
Tech 50.0 Fund 61.0 Flow 57.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.9 · SMA20: $20.21 · SMA50: $19.87

6-Pillar Scorecard Institutional Category Breakdown (GNL 3 – 3 SBRA)

Columns: Metric · GNL · SBRA
1. Valuation Multiples SBRA
Forward P/E N/M 30.4x
Trailing P/E N/M 75.7x
PEG Ratio N/M 5.28x
EV / Revenue 3.2x 8.4x
2. Growth & Scale SBRA
Revenue Growth (YoY) -6.7% +31.6%
Earnings Growth (YoY) +333.0% +22.2%
TTM Revenue (USD) $452M $924M
Market Cap $1.5B $5.4B
3. Profitability & Quality GNL
Gross Margin 86.7% 49.6%
Operating Margin 34.8% 18.4%
Net Profit Margin -2.1% 7.7%
Return on Equity (ROE) -0.8% 2.5%
4. Balance Sheet & Cash Flow GNL
Cash Generation (TTM) $332M EBITDA $401M
Cash Flow Margin 73.5% EBITDA Mgn 43.3%
Net Cash / Leverage $6.91 Book/Sh · -0.8% ROE $2.42B Net Debt (0.86x D/E)
Dividend Yield 11.36% 5.92%
5. Options & Positioning SBRA
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile 204.7% (100th %ile) 27.4% (17th %ile)
Put/Call OI Skew N/A 0.19x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat GNL
OpEx & R&D Intensity 51.9% of Rev ($234M) 31.2% of Rev ($288M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role REIT - Diversified Operator REIT - Healthcare Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GNL (2) vs SBRA (8)
Institutional Metric GNL SBRA Criterion Row Edge
Market Capitalization
Scale
$1.5B $5.4B Larger Scale SBRA
Trailing P/E Ratio
Valuation
N/M 75.7x Lower Multiple SBRA
Forward P/E Ratio
Valuation
N/M 30.4x Lower Multiple SBRA
Revenue Growth (YoY)
Growth
-6.7% +31.6% Higher Growth SBRA
Operating Margin (TTM)
Profitability
34.8% 18.4% Higher Margin GNL
Net Profit Margin
Profitability
-2.1% 7.7% Higher Margin SBRA
Return on Equity (ROE)
Capital Efficiency
-0.8% 2.5% Higher ROE SBRA
52-Week Range Position
Momentum
1% ($6–$10) 52% ($18–$23) Stronger Trend SBRA
Beta / 30D Volatility
Risk Regime
0.21β · 29% Vol 0.00β · 30% Vol Lower Realized Risk GNL
Unified Institutional Score
Composite Signal
29.1 / 100 (SELL) 58.3 / 100 (HOLD) Higher Composite SBRA
Trailing 12M Revenue (USD)
Operating Scale
$452M $924M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
86.7% 49.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 3.2x EV/Rev 5.28x PEG · 8.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$332M EBITDA ($6.91 Book/Sh · -0.8% ROE) $401M ($2.42B Net Debt (0.86x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBRA +20.44 pp
GNL: -14.28% · SBRA: +6.16%
3M Horizon SBRA +28.97 pp
GNL: -30.36% · SBRA: -1.39%
6M Horizon SBRA +29.08 pp
GNL: -32.67% · SBRA: -3.59%
1Y Horizon SBRA +29.58 pp
GNL: -20.97% · SBRA: +8.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNL vs SBRA. Trailing 12-month operating profitability (GNL 34.8% vs SBRA 18.4%) and valuation multiples (GNL N/M vs SBRA 30.4x Forward P/E) are benchmarked directly in Pillar 4 below.

GNL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$452M
Gross Margin86.7%
Op. Margin34.8%
ROE / Fwd P/E-0.8% · N/M
SBRA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$924M
Gross Margin49.6%
Op. Margin18.4%
ROE / Fwd P/E2.5% · 30.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GNL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 204.7%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GNL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
80d in phase · OBV DISTRIBUTION
Current IV 27.4%
IV Percentile 17th %ile
Put/Call OI Skew 0.19x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact SBRA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GNL Moat Profile High-Margin Pricing Power Moat
REIT - Diversified Operator
Competes within the REIT - Diversified value chain with $1.5B market capitalization and 34.8% operating margin.
OpEx & R&D Reinvestment 51.9% of Rev ($234M)
90D Engineering Disclosures 0 Published
SBRA Moat Profile Scale & Operating Efficiency Moat
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($288M)
90D Engineering Disclosures 0 Published

Investor FAQ GNL vs SBRA Key Questions & Quantitative Answers

As of Nov 17, 2026, Sabra Healthcare REIT, Inc. (SBRA) is the stronger overall head-to-head candidate over Global Net Lease, Inc. (GNL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). GNL carries a Unified Composite Score of 29.1/100 (SELL) at $6.28 (N/M Forward P/E, 34.8% operating margin), whereas SBRA carries 58.3/100 (HOLD) at $20.25 (30.4x Forward P/E, 18.4% operating margin). Technical & Structure Timing Caution: GNL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 20.0); meanwhile SBRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SBRA leads the Growth & Scale pillar: GNL posts -6.7% YoY revenue growth and +333.0% YoY earnings growth on $452M TTM revenue (86.7% gross margin, 34.8% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). On trailing 12-month operating scale, GNL generates $452M in USD-normalized revenue versus $924M for SBRA. In operating R&D and SG&A reinvestment, GNL deploys 51.9% of Rev ($234M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.

SBRA screens cheaper on headline valuation multiples. GNL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (73.5% EBITDA margin), whereas SBRA trades at 30.4x Forward P/E, 75.7x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GNL (-0.8% ROE) versus SBRA (2.5% ROE) capital efficiency.

In options market volatility and institutional positioning, GNL carries 204.7% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.21β · 29% Vol realized risk). By comparison, SBRA carries 27.4% implied volatility (17th %ile, Compressed (<25th %ile)), a 0.19x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.00β · 30% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.